Topics

FDA Approves Lifesaving Treatment For Drug-Resistant Tuberculosis, Hard-To-Cure Patients

09:50 EDT 15 Aug 2019 | Kaiser Health News

Pretomanid, approved for use with two other antibiotics, will be used for the toughest cases. Tuberculosis has surpassed AIDS as the world's leading cause of infectious death. The drug was developed by a nonprofit group called TB Alliance at a time when few companies are investing in creating next-generation antibiotics.

Original Article: FDA Approves Lifesaving Treatment For Drug-Resistant Tuberculosis, Hard-To-Cure Patients

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Lifesaving Treatment For Drug-Resistant Tuberculosis, Hard-To-Cure Patients"

Quick Search

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.